top of page

Vetenskapliga studier på mRNA

Frozen shoulder after COVID-19 vaccination

MISC

Herbal medicine use in Republic of Korea to alleviate side effects of COVID-19 vaccines, A cross-sectional study

MISC

Late Gadolinium Enhancement after COVID-19 Vaccination

MISC

Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients

MISC

Post-COVID-19 vaccination shoulder abscess and pleuroparenchymal pulmonary lesion due to Burkholderia pseudomallei

MISC

Prolonged shoulder dysfunction after coronavirus disease vaccination, A case of shoulder injury related to vaccine administration

MISC

SARS-CoV-2 mass vaccination, Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developers

MISC

SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro

MISC

Severe Covid-19 Vaccine Side-Effects are Rare in Older Adults yet are Linked With Depressive Symptoms

MISC

Short-term outcome of late gadolinium changes detected on cardiovascular magnetic resonance imaging following coronavirus disease 2019 Pfizer BioNTech vaccine-related myocarditis in adolescents

MISC

Shoulder injury linked to the administration of the SARS-CoV-2 vaccine, Blessure à l’épaule liée à l’administration du vaccin anti-SRAS-CoV-2

MISC

Shoulder injury related to vaccine administration (SIRVA) following mRNA COVID-19 vaccination, Report of 2 cases of subacromial-subdeltoid bursitis

MISC

Shoulder Pain and Injury after COVID-19 Vaccination

MISC

SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination, Case discussion and literature review

MISC

Subacromial-subdeltoid bursitis following COVID-19 vaccination, a case of shoulder injury related to vaccine administration (SIRVA)

MISC

Symptomology following mRNA vaccination against SARS-CoV-2

MISC

The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune responses

MISC

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

MISC

The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

MISC

12yoM A Case of Multisystem Inflammatory Syndrome in a 12-Year-old Male After COVID-19 mRNA Vaccine

MIS-V

World Council for Health Danmark

©2024 av World Council for Health Denmark.

Sekretesspolicy

bottom of page